首页> 外文期刊>Journal of land use science >Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania (V.) braziliensis and Leishmania (L.) amazonensis
【24h】

Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania (V.) braziliensis and Leishmania (L.) amazonensis

机译:由于Leishmania(V.)巴西(V.)巴西(V.)巴西(V.)巴西(V.)巴西(V.)和Leishmania(L.)Amazonensis,在整个皮肤吉尔曼病的整个临床和免疫病理学谱的情况下的收费2,4和9个表达。

获取原文
获取原文并翻译 | 示例
       

摘要

Leishmania (V.) braziliensis and Leishmania(L.) amazonensis are the most pathogenic agents of American Cutaneous Leishmaniasis in Brazil, causing a wide spectrum of clinical and immunopathological manifestations, including: localized cutaneous leishmaniasis (LCLDTH+/++), borderline disseminated cutaneous leishmaniasis (BDCLDTH), anergic diffuse cutaneous leishmaniasis (ADCLDTH-), and mucosal leishmaniasis (MLDTH++++). It has recently been demonstrated, however, that while L. (V.) braziliensis shows a clear potential to advance the infection from central LCL (a moderate T-cell hypersensitivity form) towards ML (the highest T-cell hypersensitivity pole), L. (L.) amazonensis drives the infection in the opposite direction to ADCL (the lowest T-cell hypersensitivity pole). This study evaluated by immunohistochemistry the expression of Toll-like receptors (TLRs) 2, 4, and 9 and their relationships with CD4 and CD8 T-cells, and INF-a, IL-10, and TGF-6 cytokines in that disease spectrum. Biopsies of skin and mucosal lesions from 43 patients were examined: 6 cases of ADCL, 5 of BDCL, and 11 of LCL caused byL. (L.) amazonensis; as well as 10 cases of LCL, 4 of BDCL, and 6 of ML caused byL. (V.) braziliensis. CD4(+) T-cells demonstrated their highest expression in ML and, in contrast, their lowest in ADCL. CD8(+) T-cells also showed their lowest expression in ADCL as compared to the other forms of the disease. INF-alpha(+)showed increased expression from ADCL to ML, while IL-10(+)and TGF-6(+) showed increased expression in the opposite direction, from ML to ADCL. With regards to TLR2, 4, and 9 expressions, strong interactions of TLR2 and 4 with clinical forms associated with L. (V.) braziliensis were observed, while TLR9, in contrast, showed a strong interaction with clinical forms linked to L. (L.) amazonensis. These findings strongly suggest the ability of L. (V.) braziliensis and L. (L.)
机译:Leishmania(V.)巴西和利什曼尼亚(L.)亚马逊是巴西美国皮肤莱山西亚体的最致病剂,造成广泛的临床和免疫病理表现,包括:局部皮肤leishmaniaisis(Lcldth + / ++),边界传播皮肤LeishManiaisis(BDCLDTH),白血病弥漫性皮肤Leishmaniais(Adcldth-)和粘膜LeishManiaisis(MLDTH ++++)。然而,最近已经证明了,而L.(V.)巴西人显示出透明潜力,可以将感染从中央LCL(适度T细胞过敏形式)朝向ML(最高T细胞超敏杆),L 。(L.)Amazonensis将相反方向的感染驱动到ADCL(最低T细胞超敏杆)。本研究通过免疫组织化学评估了Toll样受体(TLRS)2,4和9的表达及其与CD4和CD8 T细胞的关系,以及该疾病谱中的INF-A,IL-10和TGF-6细胞因子。 。检查了43名患者的皮肤和粘膜病变的活组织检查:6例ADCL,5例BDCl,11例LCL引起的。 (L.)amazonensis;以及10例LCl,4个BDCl和6毫升引起的6例。 (V.)巴西。 CD4(+)T细胞证明了它们在M1中的最高表达,相反,它们在AdCl中最低。与其他形式的疾病相比,CD8(+)T细胞还显示它们在Adcl中的最低表达。 INF-α(+)显示从AdCl到mL的表达增加,而IL-10(+)和TGF-6(+)显示出呈相反方向的增加的表达,从Ml到AdCl。关于TLR2,4和9个表达,TLR2和4具有与L.(V.)巴西相关的临床形式的强相互作用,相比之下,TLR9显示出与与L相关的临床形式的强相互作用。( L.)Amazonensis。这些发现强烈建议L.(V.)Braziliensis和L.(L.)的能力

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号